Ataluren in cystic fibrosis: development, clinical studies and where are we now? (2017)
Attributed to:
Investigation into the role of ceramide in the pathogenesis of cystic fibrosis lung disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/14656566.2017.1359255
PubMed Identifier: 28730885
Publication URI: http://europepmc.org/abstract/MED/28730885
Type: Journal Article/Review
Volume: 18
Parent Publication: Expert opinion on pharmacotherapy
Issue: 13
ISSN: 1465-6566